Cramer Rosenthal McGlynn’s Cardinal Health CAH Stock Holding History

Cramer Rosenthal McGlynn’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-309,981	Closed	-$25.9M	–	239
2015 Q2	$25.9M	Sell	309,981 -124,765	-29%	-$11M	0.32%	115
2015 Q1	$39.2M	Sell	434,746 -183,711	-30%	-$15.8M	0.44%	98
2014 Q4	$49.9M	Sell	618,457 -289,804	-32%	-$22.9M	0.51%	78
2014 Q3	$68M	Sell	908,261 -150,293	-14%	-$10.9M	0.68%	53
2014 Q2	$72.6M	Buy	1,058,554 +416,858	+65%	+$28.4M	0.58%	65
2014 Q1	$44.9M	Sell	641,696 -134,781	-17%	-$9.37M	0.34%	110
2013 Q4	$51.9M	Sell	776,477 -1,542,300	-67%	-$94.3M	0.37%	98
2013 Q3	$121M	Sell	2,318,777 -480,739	-17%	-$24.4M	0.91%	38
2013 Q2	$132M	Buy	+2,799,516	New	+$128M	1%	30

Other funds holding CAH

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

LTI

Laffer Tengler Investments Nashville, Tennessee $677M AUM 27.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Cramer Rosenthal McGlynn's CAH Position: Q3 2015 in Review

Cramer Rosenthal McGlynn sold out of Cardinal Health (CAH) in Q3 2015, closing a stake of 309,981 shares — an estimated $25.9M sold.

Cramer Rosenthal McGlynn first reported a position in CAH in Q2 2013 and held it in 9 quarters. The position peaked at $132M in Q2 2013. 756 funds tracked by Wall St. Rank hold CAH as of Q3 2015.

Cramer Rosenthal McGlynn reported no remaining Cardinal Health position as of Q3 2015 after selling out during the quarter.
Cramer Rosenthal McGlynn sold 309,981 Cardinal Health shares in Q3 2015, an estimated $25.9M.
Cramer Rosenthal McGlynn first reported a position in Cardinal Health in Q2 2013 and held it in 9 quarters.
Cramer Rosenthal McGlynn's Cardinal Health position peaked at $132M in Q2 2013.
756 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2015.

Based on Cramer Rosenthal McGlynn's 13F filing for Q3 2015, filed 13 Nov 2015.